Cargando…

Correction to: Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy

Detalles Bibliográficos
Autores principales:	Wei, Jia, Ma, Ling, Lai, Yi-Hui, Zhang, Ruijie, Li, Huameng, Li, Chenglong, Lin, Jiayuh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706875/ https://www.ncbi.nlm.nih.gov/pubmed/31443669 http://dx.doi.org/10.1186/s13046-019-1381-y

Ejemplares similares

Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019)

Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
por: Xiao, Hui, et al.
Publicado: (2017)

Inhibition of Interleukin‐6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice
por: Shi, Wei, et al.
Publicado: (2020)

Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling
por: Wang, Yina, et al.
Publicado: (2017)

Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer
por: Park, Sun-Ae, et al.
Publicado: (2022)

Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer
por: Kim, Leekyung, et al.
Publicado: (2021)

Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma
por: Ma, Haiyan, et al.
Publicado: (2019)

Bazedoxifene Attenuates Abdominal Aortic Aneurysm Formation via Downregulation of Interleukin-6/Glycoprotein 130/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Apolipoprotein E–Knockout Mice
por: Yan, Dan, et al.
Publicado: (2020)

Author Correction: gp130/STAT3 signaling is required for homeostatic proliferation and anabolism in postnatal growth plate and articular chondrocytes
por: Liu, Nancy Q., et al.
Publicado: (2022)

Correction for Forced Homo- and Heterodimerization of All gp130-Type Receptor Complexes Leads to Constitutive Ligand-independent Signaling and Cytokine-independent Growth
Publicado: (2011)

Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
por: Looyenga, Brendan D., et al.
Publicado: (2014)

Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome
por: Arlabosse, Tiphaine, et al.
Publicado: (2023)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

The Role of gp130 Cytokines in Tuberculosis
por: Ritter, Kristina, et al.
Publicado: (2020)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Update on bazedoxifene: A novel selective estrogen receptor modulator
por: Biskobing, Diane M
Publicado: (2007)

Bazedoxifene as a novel strategy for treatment of pancreatic and gastric adenocarcinoma
por: Burkhardt, Claudia, et al.
Publicado: (2019)

A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin
por: Zhang, Ruijie, et al.
Publicado: (2021)

Correction to: GP2015: An Etanercept Biosimilar
por: Deeks, Emma D.
Publicado: (2018)

LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
por: Zuo, Mingxin, et al.
Publicado: (2015)

Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells
por: Zhao, Chengguang, et al.
Publicado: (2015)

GP130 Cytokines in Breast Cancer and Bone
por: Omokehinde, Tolu, et al.
Publicado: (2020)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Correction to: PF-06438179/GP1111: An Infliximab Biosimilar
por: Al-Salama, Zaina T.
Publicado: (2018)

New insights into the role and signalling processes of gp130
por: Rose-John, Stefan
Publicado: (2011)

The two facets of gp130 signalling in liver tumorigenesis
por: Schmidt-Arras, Dirk, et al.
Publicado: (2021)

IL-6/gp130 signaling: a key unlocking regeneration
por: Li, Ruopu, et al.
Publicado: (2023)

A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells
por: Zhao, Chongqiang, et al.
Publicado: (2016)

Correction: Novel tech throws knock-out punch to ECG improving GP referral decisions to cardiology
Publicado: (2022)

Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan
por: Ohta, H., et al.
Publicado: (2014)

Effects of lasofoxifene and bazedoxifene on B cell development and function
por: Bernardi, Angelina I, et al.
Publicado: (2014)

Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis
por: Hill, Amanda M., et al.
Publicado: (2018)

Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice
por: Noirrit, Emmanuelle, et al.
Publicado: (2019)

Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144
por: Pozios, Ioannis, et al.
Publicado: (2022)

The Dynamics of Signal Triggering in a gp130-Receptor Complex
por: Matadeen, Rishi, et al.
Publicado: (2007)

Roles of IL-6-gp130 Signaling in Vascular Inflammation
por: Hou, Tieying, et al.
Publicado: (2008)

Correction: Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers
por: Zhang, Ye, et al.
Publicado: (2021)

Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012)

Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy
por: Ouyang, Qi, et al.
Publicado: (2020)

Bazedoxifene does not share estrogens effects on IgG sialylation
por: Gupta, Priti, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4u2ip45ccan5kn4ljouujs8j9i